Chang Dae Bae

Title: Chang Dae Bae: Innovator in Cancer Prognosis Prediction

Introduction

Chang Dae Bae is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of cancer research, particularly in the area of cancer prognosis prediction. His innovative work has the potential to impact the way cancer is diagnosed and treated.

Latest Patents

Chang Dae Bae holds a patent for a composition aimed at cancer prognosis prediction. The patent, titled "Composition for cancer prognosis prediction comprising anti-TMAP/CKAP2 antibodies," relates to an antibody that specifically binds to TMAP (tumor associated microtubule associated protein) and CKAP2 (cytoskeleton associated protein 2). This invention includes methods for identifying the presence or absence of mitosis and diagnosing cancer prognosis. The composition can be used to detect TMAP/CKAP2 and provides valuable information for diagnosing cancer prognosis.

Career Highlights

Throughout his career, Chang Dae Bae has worked with esteemed institutions such as the National Cancer Center and Sungkyunkwan University. His experience in these organizations has allowed him to collaborate with leading experts in the field of cancer research.

Collaborations

Chang Dae Bae has collaborated with notable colleagues, including Joo Bae Park and Yong Book Choi. These partnerships have contributed to the advancement of his research and the development of innovative solutions in cancer prognosis.

Conclusion

Chang Dae Bae is a pioneering inventor whose work in cancer prognosis prediction is making a significant impact in the medical field. His contributions through innovative patents and collaborations with esteemed institutions highlight his dedication to advancing cancer research.